Analysis Method of Real-World Digital Biomarkers for Clinical Impact in Cancer Patients.

Saved in:
Bibliographic Details
Title: Analysis Method of Real-World Digital Biomarkers for Clinical Impact in Cancer Patients.
Authors: Oakley-Girvan I; Medable Inc., Strategy and Science Departments, Palo Alto, CA, USA.; Public Health Institute, The Data and Technology Proving Ground, Oakland, CA, USA., Zhai Y; Vivosense, Inc., Newport Coast, CA, USA., Yunis R; Medable Inc., Strategy and Science Departments, Palo Alto, CA, USA., Liu R; Kaiser Permanente Northern California, Division of Research, Oakland, CA, USA.; Kaiser Permanente Northern California, Department of Hematology Oncology, San Francisco, CA, USA., Davis SW; Medable Inc., Strategy and Science Departments, Palo Alto, CA, USA., Kubo A; Kaiser Permanente Northern California, Division of Research, Oakland, CA, USA., Aghaee S; Kaiser Permanente Northern California, Division of Research, Oakland, CA, USA., Blankenship JM; Vivosense, Inc., Newport Coast, CA, USA., Lyden K; Vivosense, Inc., Newport Coast, CA, USA., Neeman E; Kaiser Permanente Northern California, San Rafael Medical Center, San Rafael, CA, USA.
Source: Digital biomarkers [Digit Biomark] 2025 Feb 03; Vol. 9 (1), pp. 40-51. Date of Electronic Publication: 2025 Feb 03 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: S. Karger AG Country of Publication: Switzerland NLM ID: 101707633 Publication Model: eCollection Cited Medium: Internet ISSN: 2504-110X (Electronic) Linking ISSN: 2504110X NLM ISO Abbreviation: Digit Biomark Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2504-110X
DOI:10.1159/000543898